In fact, cancer cells lacking p53 or expressing loss-of-function p53 mutants are resistant to chemotherapeutic drugs in part due to their lack of mitochondrial Ca2+ overload, as these cells can be re-sensitized to chemotherapeutics by overexpressing MCU (120, 166). The gene discussed is TP53; the disease is cancer.